Similar results have been observed in other tumor types, such as non–small cell lung cancer, in which PD-L1 expression on ICs was found to be regulated by adaptive IFNγ-mediated mechanisms associated with increased tumor-infiltrating lymphocytes and effector T cells (28). The gene discussed is IFNG; the disease is neoplasm.